Controlled Substances in the Polydrug Epidemic: Response to Diller

Am J Psychiatry. 2019 Jan 1;176(1):78. doi: 10.1176/appi.ajp.2018.18080948r2.

Authors

Robert L DuPont¹, Amelia M Arria¹

Affiliation

¹ Institute for Behavior and Health, Rockville, Md. (DuPont); Center on Young Adult Health and Development, Department of Behavioral and Community Health, University of Maryland School of Public Health, College Park (Arria).

PMID: 30848950
DOI: 10.1176/appi.ajp.2018.18080948r2

No abstract available

Keywords: ADHD; CNS Stimulants; Epidemiology; Psychoactive Substance Use Disorder; Stimulant Abuse.

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Adult
Attention Deficit Disorder with Hyperactivity*
Central Nervous System Stimulants*
Controlled Substances*
Humans
Motivation
Prevalence
United States

Substances

Central Nervous System Stimulants
Controlled Substances

Grants and funding

U01 DA040219/DA/NIDA NIH HHS/United States